Dr. Reddy's Laboratories Ltd (RDY) vs Zoetis Inc. (ZTS)
- Dr. Reddy's Laboratories Ltd RDY 14.53 −1.62%
- Zoetis Inc. ZTS 81.72 −8.39%
Dr. Reddy's Laboratories Ltd and Zoetis Inc. are both Drug Manufacturers Specialty & Generic companies. Zoetis Inc. is the larger, with a market value of $33.9B against $12.1B — 2.8× the size. Zoetis Inc. trades at the lower P/E: 13.4× against 44.4×. Zoetis Inc. grew revenue faster over the last twelve months: 1.58% against −15.5%. Zoetis Inc. has the higher net margin (27.7% vs 8.06%) and the higher return on invested capital (19.6% vs 4.77%). Only Zoetis Inc. pays a dividend (2.59%). Across the 23 metrics below, Zoetis Inc. leads on 18 and Dr. Reddy's Laboratories Ltd on 5.
Valuation
Profitability
| Metric | RDY | ZTS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 49.16% | 71.67% | 53.51% |
| Operating margin | 9.20% | 37.13% | 0.00% |
| Net margin | 8.06% | 27.69% | (2.45%) |
| Free cash flow margin | 2.88% | 24.43% | 0.00% |
| Return on equity | 6.60% | 64.91% | (0.80%) |
| Return on assets | 4.44% | 17.84% | (1.67%) |
| Return on invested capital | 4.77% | 19.60% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack